MX361099B - Medicamento con sabor a anís. - Google Patents

Medicamento con sabor a anís.

Info

Publication number
MX361099B
MX361099B MX2015010286A MX2015010286A MX361099B MX 361099 B MX361099 B MX 361099B MX 2015010286 A MX2015010286 A MX 2015010286A MX 2015010286 A MX2015010286 A MX 2015010286A MX 361099 B MX361099 B MX 361099B
Authority
MX
Mexico
Prior art keywords
anise
medication
anise flavored
flavored medication
liquid medication
Prior art date
Application number
MX2015010286A
Other languages
English (en)
Other versions
MX2015010286A (es
Inventor
Michael Kaufmann Alllyn
Carl Grimm James
Lynn Brewster Chelsay
Edward Huetter Thomas
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX2015010286A publication Critical patent/MX2015010286A/es
Publication of MX361099B publication Critical patent/MX361099B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/17—Nitrogen containing
    • Y10T436/173845—Amine and quaternary ammonium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un medicamento líquido con sabor a anís. El medicamento líquido contiene fenilefrina y un análogo del anetol que está sustancialmente libre de grupos aldehído. En un ejemplo, el análogo del anetol puede ser 1-metoxi-4-n-propilbenceno.
MX2015010286A 2013-02-13 2014-02-13 Medicamento con sabor a anís. MX361099B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361764002P 2013-02-13 2013-02-13
PCT/US2014/016238 WO2014127118A1 (en) 2013-02-13 2014-02-13 Anise flavored medication

Publications (2)

Publication Number Publication Date
MX2015010286A MX2015010286A (es) 2015-10-29
MX361099B true MX361099B (es) 2018-11-27

Family

ID=50193605

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015010286A MX361099B (es) 2013-02-13 2014-02-13 Medicamento con sabor a anís.

Country Status (11)

Country Link
US (4) US9457085B2 (es)
EP (1) EP2956120B1 (es)
CN (1) CN104936578A (es)
AU (1) AU2014216275B2 (es)
BR (1) BR112015019347B1 (es)
CA (1) CA2899492C (es)
ES (1) ES2795291T3 (es)
MX (1) MX361099B (es)
PL (1) PL2956120T3 (es)
RU (1) RU2625550C2 (es)
WO (1) WO2014127118A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2625550C2 (ru) 2013-02-13 2017-07-14 Дзе Проктер Энд Гэмбл Компани Ароматизированное анисом лекарственное средство
CN105699555B (zh) * 2016-03-24 2018-09-11 中国标准化研究院 一种丙烯基乙基愈创木酚的液相色谱制备方法
US10086026B2 (en) * 2016-06-27 2018-10-02 Uwais M. Syed Combined herbal and pharmaceutical composition and method
AU2017321700A1 (en) * 2016-09-01 2019-02-07 The Procter & Gamble Company Medication with improved taste and sensory experience
GR1009462B (el) * 2017-10-05 2019-02-15 Laboserve Φαρμακευτικη Βιομηχανια Α.Ε. Ποσιμο φαρμακευτικο διαλυμα με συγκαλυμμενη γευση

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0714872B2 (ja) 1990-02-06 1995-02-22 昭和薬品化工株式会社 シロップ剤組成物
WO1991012792A1 (en) 1990-03-02 1991-09-05 The Partnership Of Isaac G. Eliaz And Shmuel Gonen Method and product for promoting hair growth and treating skin conditions
US5458879A (en) 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
BE1011045A3 (fr) 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
US6599883B1 (en) 1998-10-30 2003-07-29 Nastech Pharmaceutical Company, Inc. Nasal delivery of xylitol
PT1997478E (pt) 2001-02-15 2013-12-10 Access Pharma Inc Formulações líquidas para a prevenção e para o tratamento de doenças e distúrbios das mucosas
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US20080300314A1 (en) 2003-11-21 2008-12-04 Givaudan Sa Cooling Compounds
CN100582089C (zh) 2003-11-21 2010-01-20 吉万奥丹股份有限公司 N-取代的对-薄荷烷甲酰胺
US20060188450A1 (en) 2005-02-24 2006-08-24 Tim Clarot System and method for suppressing a cough
CN101346073B (zh) 2005-12-23 2013-02-13 卡夫食品环球品牌有限责任公司 提供基本上类似于由薄荷醇提供的感觉的组合物
US20080014267A1 (en) 2006-07-12 2008-01-17 Everett Laboratories, Inc. Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
US20070178123A1 (en) 2006-01-27 2007-08-02 Deborah Levenson Flavor-enhancing compositions, method of manufacture, and methods of use
US20070249727A1 (en) * 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US9155769B2 (en) * 2006-07-07 2015-10-13 The Procter & Gamble Co Flavor oils with reduced dimethyl sulfoxide content and use in oral compositions
US9005652B2 (en) 2006-07-25 2015-04-14 Wyeth Chewable tablet containing phenylephrine
US9078824B2 (en) 2007-09-24 2015-07-14 The Procter & Gamble Company Composition and method of stabilized sensitive ingredient
CA2706472A1 (en) 2007-11-21 2009-05-28 The Procter & Gamble Company Preparations, methods and kits useful for treatment of cough
PE20091084A1 (es) * 2007-12-07 2009-07-23 Schering Plough Healthcare Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
ES2538789T3 (es) 2008-08-15 2015-06-24 The Procter & Gamble Company Síntesis de derivados de ciclohexano útiles como compuestos refrescantes en productos de consumo
WO2010059289A1 (en) 2008-11-20 2010-05-27 The Procter & Gamble Company Personal care compositions providing enhanced cooling sensation
US8962057B2 (en) * 2009-04-29 2015-02-24 The Procter & Gamble Company Methods for improving taste and oral care compositions with improved taste
US8664261B2 (en) 2009-05-05 2014-03-04 Givaudan S.A. Organic compounds having cooling properties
US20110195042A1 (en) * 2010-02-10 2011-08-11 Thomas Edward Huetter Compositions, Methods and Kits Useful for Treating a Respiratory Symptom
RU2625550C2 (ru) 2013-02-13 2017-07-14 Дзе Проктер Энд Гэмбл Компани Ароматизированное анисом лекарственное средство
GB201314049D0 (en) 2013-08-06 2013-09-18 Rolls Royce Plc Bearing cage deflector

Also Published As

Publication number Publication date
WO2014127118A1 (en) 2014-08-21
RU2015128789A (ru) 2017-03-17
PL2956120T3 (pl) 2020-08-10
US20140228391A1 (en) 2014-08-14
BR112015019347B1 (pt) 2022-12-20
AU2014216275A1 (en) 2015-08-06
CA2899492C (en) 2019-09-17
US20180064661A1 (en) 2018-03-08
MX2015010286A (es) 2015-10-29
US9457085B2 (en) 2016-10-04
CN104936578A (zh) 2015-09-23
EP2956120A1 (en) 2015-12-23
US20180344670A1 (en) 2018-12-06
US10588872B2 (en) 2020-03-17
CA2899492A1 (en) 2014-08-21
US10071067B2 (en) 2018-09-11
AU2014216275B2 (en) 2018-03-15
RU2625550C2 (ru) 2017-07-14
ES2795291T3 (es) 2020-11-23
EP2956120B1 (en) 2020-04-15
US9839620B2 (en) 2017-12-12
US20160361277A1 (en) 2016-12-15
BR112015019347A2 (pt) 2017-07-18

Similar Documents

Publication Publication Date Title
AU356301S (en) Injection device with cap on
MX2016006036A (es) Composicion de fotocromatica.
EP3000065A4 (en) Phenotypic integrated social search database and method
AU356110S (en) Cap
EP2981942A4 (en) CONTENTS BASED ON SOCIAL RECOMMENDATIONS
MX2015017928A (es) Montajes de mezclado incluyendo impulsores magneticos.
AU353870S (en) Tablet PC
PL3055993T3 (pl) Wyświetlanie dci i innej treści na projektorze o rozszerzonym zakresie dynamiki
AU354141S (en) Bottle
CA152180S (en) Analytical apparatus for drug testing
PH12017500052A1 (en) Myo-inositol and probiotics and uses
EP2979717A4 (en) SYRINGE WITH INJECTION NEEDLE AND METHOD FOR MANUFACTURING SYRINGE WITH INJECTION NEEDLE
MX2015010286A (es) Medicamento con sabor a anis.
AR095583A1 (es) Recipiente que tiene un indicador de uso
AU362346S (en) Analyte meter
AP2016009128A0 (en) Cyclic thienouracil-carboxamides and use thereof
EP2994178A4 (en) NADELLOSIS INJECTOR SYSTEMS AND RELATED METHODS AND COMPONENTS
AU356724S (en) Electronic autoinjector
AU349910S (en) Adhesive stick
ZA201504080B (en) Combination medicament comprising phenylephrine and paracetamol
CA2902717C (en) Infusion management platform with infusion data grouping logic
PH12017500084A1 (en) Vitamin b2 and its use
SG11201506513RA (en) Business lead generation system and method using structured social media content
GB2510444B (en) Combination of phenylephrine and paracetamol
MX2014002828A (es) El metodo para proceso de informacion y sistema para proceso de informacion.

Legal Events

Date Code Title Description
FG Grant or registration